Effect of N-acetyl-l-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis-Reference-Cited by-同舟云学术

Effect of N-acetyl-l-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis

Published:2002-12 Issue:4 Volume:7 Page:277-282
ISSN:1089-8603
Container-title:Nitric Oxide
language:en
Short-container-title:Nitric Oxide

Author:

Failli Paola,Palmieri Loredana,D’Alfonso Caterina,Giovannelli Lisa,Generini Sergio,Rosso Angela Del,Pignone Alberto,Stanflin Nirvana,Orsi Stefano,Zilletti Lucilla,Matucci-Cerinic Marco

Publisher

Elsevier BV

Subject

Cancer Research,Clinical Biochemistry,Physiology,Biochemistry

Reference32 articles.

1. Increased nitric oxide in exhaled air in patients with systemic sclerosis;Fajac;Clin. Exp. Rheumatol.,1998

2. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension;Kharitonov;Thorax,1997

3. Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension;Rolla;Lancet,1998

4. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis;Yamamoto;J. Rheumatol.,1998

5. Increased production of nitric oxide stimulated by interleukin-1 β in peripheral blood mononuclear cells in patients with systemic sclerosis;Yamamoto;Br. J. Rheumatol.,1998

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review;Frontiers in Medicine;2022-04-29

2. Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis;Frontiers in Endocrinology;2021-09-28

3. Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment;Journal of Immunology Research;2021-06-24

4. Hallmarks of Aging in Macrophages: Consequences to Skin Inflammaging;Cells;2021-05-26

5. Preventing the development of severe COVID-19 by modifying immunothrombosis;Life Sciences;2021-01